Nanomix: Tadd Lazarus
Nanomix has appointed Tadd Lazarus to its board of directors as an independent director. Lazarus has served as chief medical officer at multiple biotechnology companies, including Achieve Health Management, Inivata, and Clinical Genomics. From 2013 to 2016, he was CMO and head of medical and scientific affairs, reimbursement, and public policy at Qiagen and before that served as CMO and VP of clinical affairs at Gen-Probe (now Hologic). Lazarus also held multiple positions at Roche Diagnostics, including director of medical and scientific affairs and North American medical director for the molecular diagnostics, point-of-care, diabetes, clinical chemistry, and immunology businesses.